CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2022; 43(03): 270-277
DOI: 10.1055/s-0042-1749400
Original Article

Complementary and Alternative Treatment Use in Breast Cancer Patients in the Eastern Black Sea Region—A Cross-Sectional Study

1   Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
,
1   Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
,
1   Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
,
1   Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
,
1   Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
› Author Affiliations
Funding None.

Abstract

Introduction Complementary and alternative therapies (CAMs) are being increasingly and frequently used in the treatment of cancer patients in the last two decades.

Objectives It was aimed to examine the frequency of the use of CAMs in patients with breast cancer who applied to the outpatient clinic.

Materials and Methods Patients who were admitted to our clinic between January 2020 and 2021 and diagnosed with breast cancer for at least 3 months were included in the study. A questionnaire consisting of 37 questions was asked to the patients by the interviewer. Sociodemographic characteristics and CAM methods of the patients were questioned in the questionnaire.

Results This is a cross-sectional study that includes 338 patients. After the questionnaire was completed, the answers were evaluated, and it was detected that 147 (43.4%) patients were using CAM. Herbal treatment methods were preferred most frequently. The most frequently used herbs were turmeric, nettle, ginger, and linden. The second method used was treatments based on religious belief. The use of CAM increased as the income level of the patients increased and the duration of diagnosis increased.

Conclusion It was determined that our patients frequently used CAM methods and mostly preferred herbal methods. Since the use of CAMs during or after treatment may create undesirable results in the treatment of patients, it is necessary to be careful about this issue and inform as well as question the patients about the same.

Ethics

The research was conducted out in line with the principles of the Declaration of Helsinki and was approved by the local ethical committee (No. 2020/31), dated 11.06.2020. The patients were included in the study after the written consent form was read and their signed consent was obtained. After oral explanation was given to illiterate patients and their consent was obtained, a questionnaire was administered in the presence of their attendants.




Publication History

Article published online:
02 July 2022

© 2022. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
  • 2 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin 2021; 71 (01) 7-33
  • 3 Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist 2004; 9 (01) 80-89
  • 4 Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002; 137 (11) 889-903
  • 5 Fremd C, Hack CC, Schneeweiss A. et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Arch Gynecol Obstet 2017; 295 (05) 1239-1245
  • 6 Molassiotis A, Fernández-Ortega P, Pud D. et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005; 16 (04) 655-663
  • 7 Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 2012; 11 (03) 187-203
  • 8 Greenlee H, Balneaves LG, Carlson LE. et al; Society for Integrative Oncology. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014; 2014 (50) 346-358
  • 9 Bebis H, Akpunar D, Coşkun S, Özdemir S. Complementary and alternative treatments in patients with breast cancer: a literature review. J Educ Res Nurs 2014; 11 (02) 6-15
  • 10 Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer 2011; 11: 196
  • 11 Kristoffersen AE, Quandt SA, Stub T. Use of complementary and alternative medicine in Norway: a cross-sectional survey with a modified Norwegian version of the international questionnaire to measure use of complementary and alternative medicine (I-CAM-QN). BMC Complement Med Ther 2021; 21 (01) 93
  • 12 Nayeri ND, Bakhshi F, Khosravi A, Najafi Z. The effect of complementary and alternative medicines on quality of life in patients with breast cancer: a systematic review. Indian J Palliat Care 2020; 26 (01) 95-104
  • 13 Findley PA, Sambamoorthi U. Preventive health services and lifestyle practices in cancer survivors: a population health investigation. J Cancer Surviv 2009; 3 (01) 43-58
  • 14 Fouladbakhsh JM, Stommel M. Gender, symptom experience, and use of complementary and alternative medicine practices among cancer survivors in the U.S. cancer population. Oncol Nurs Forum 2010; 37 (01) E7-E15
  • 15 DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002; 20 (18, Suppl): 34S-38S
  • 16 Gray RE, Fitch M, Goel V, Franssen E, Labrecque M. Utilization of complementary/alternative services by women with breast cancer. J Health Soc Policy 2003; 16 (04) 75-84
  • 17 Kurt H, Keşkek Ş, Çil T. et al. Meme kanserli hastalarda tamamlayıcı/alternatif tedavi kullanımı. Türk Onkoloji Dergisi 2013; 28 (01) 10-15
  • 18 Yeşil H, Kıran B, Alkan H. et al. Afyon Kocatepe Üniversitesi'nde Meme Kanseri Tanisi İle Takip Edilmekte Olan Hastalarda Tamamlayici Ve Alternatif Tedavi Kullanimi. Kocatepe Tıp Dergisi 2018; 19 (02) 42-47
  • 19 Cui Y, Shu XO, Gao Y. et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 2004; 85 (03) 263-270
  • 20 Schönekaes K, Micke O, Mücke R. et al. [Use of complementary/alternative therapy methods by patients with breast cancer]. Forsch Komplementarmed Klass Naturheilkd 2003; 10 (06) 304-308
  • 21 Graham JG, Quinn ML, Fabricant DS, Farnsworth NR. Plants used against cancer - an extension of the work of Jonathan Hartwell. J Ethnopharmacol 2000; 73 (03) 347-377
  • 22 Ernst E. The role of complementary and alternative medicine. BMJ 2000; 321 (7269): 1133-1135
  • 23 Paul M, Davey B, Senf B. et al. Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol 2013; 139 (09) 1515-1522
  • 24 Molassiotis A, Scott JA, Kearney N. et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 2006; 14 (03) 260-267
  • 25 Mohd Mujar NM, Dahlui M, Emran NA. et al. Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia. PLoS One 2017; 12 (04) e0176394